Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States
PaperCitations, authors & open-access status
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 28 citations, 2021 year and diamond oa status.
28
Citations
2021
Year
diamond
OA Status